| Code | 1275F | ||||||||||
| MA number | 59/0318/25-S | ||||||||||
| Product Form: | cps dur 21x1x3 mg (blis.PVC/Al/OPA/Al - jednotk.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AS Olpha, Latvia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al/OPA/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.09.2025 |
| Validity: | 30.09.2030 |
| SPC: |
SPC_Pomalidomide Olpha 1 mg, 2 mg, 3 mg, 4 mg tvrdé kapsuly_cps dur_09/2025_REG.pdf
|
| PIL: |
PIL_Pomalidomide Olpha 1 mg, 2 mg, 3 mg, 4 mg tvrdé kapsuly_cps dur_09/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 17.10.2025 |
